Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Kazim,Husain

第一单位： Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.

作者： Kazim,Husain ^[1] ; Krystal,Villalobos-Ayala ^[1] ; Valentina,Laverde ^[1] ; Oscar A,Vazquez ^[1] ; Bradley,Miller ^[1] ; Samra,Kazim ^[1] ; George,Blanck ^[2] ; Margaret L,Hibbs ^[3] ; Gerald,Krystal ^[4] ; Isra,Elhussin ^[5] ; Joakin,Mori ^[5] ; Clayton,Yates ^[5] ; Tomar,Ghansah ^[2]

作者单位： Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA. ^[1] Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.;Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA. ^[2] Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne 3004, Australia. ^[3] The Terry Fox Laboratory, BC Cancer, Vancouver, BC V5Z 1L3, Canada. ^[4] Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA. ^[5]

关键词 MDSC SHIP-1 TAM apigenin miR-155 myelopoiesis pancreatic cancer tumor microenvironment

DOI 10.3390/cancers14153613

PMID 35892872

发布时间 2024-05-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交